Journal of Cardiovascular Disease Research
EFFECTIVENESS OF DAPAGLIFLOZIN IN THE MANAGEMENT OF TYPE-2 DIABETES MELLITUS IN COMBINATION WITH OTHER OHA’S &/OR INSULIN
Dr. Jai Prakash, Dr. Vikas Babu
JCDR. 2024: 1371-1378
Abstract
Background To investigate the efficacy of “dapagliflozin” in the treatment of type 2 diabetes mellitus when combined with insulin &/or other OHAs Methods At this investigation, 130 subjetcs with uncontrolled T-2 DM combined with various OHAs &/or insulin were studied at the department of medicine. Pre-made questionnaires were used to record specifics regarding each patient's family history, medical history, clinical examination, & course of therapy. In this study, dapagliflozin was administered as an adjuvant medication to all patients who have received standard treatment for their diabetes. After three months of Dapagliflozin medication, differences in HbA1c & FBS levels were assessed.
» PDF